How Techceuticals, PharmParts, and smart auction strategies are ushering in a new era of efficiency and innovation for CDMOs ...

Trends in certain forms of drug delivery, as well as the emergence of artificial intelligence, are playing roles in evolving ...

As a result of the decision, Shilpa will not be eligible to receive FDA approval for its lenvatinib mesylate generic until February 2036.

The new lab will be used to develop and scale innovations for the production of medicines and to help secure the supply chain ...

The ERVI is reviewing the EU's production capacity for metallic HALEU. It is also looking at ways to enhance the production ...

The grant encompasses $100,000 each from the Life Sciences Entrepreneurship Center and Berkeley SkyDeck, with SkyDeck having ...

Matt Cushing, VP of Quality and Science, Nelson Labs, and Susan J. Schniepp, distinguished fellow at Regulatory Compliance ...

Pharmaceutical Compounding Calculations, Part One–Non-Salts, Salts, and Policy-Exception Salts ...

A Phase III trial demonstrated mNEXSPIKE’s non-inferior efficacy compared with Moderna’s original COVID vaccine, Spikevax.

Scientific breakthroughs, operational innovation, and cultural shifts are driving tomorrow’s medicines.